Investor directory

OrbiMed

OrbiMed Advisors LLC is a healthcare-focused investment firm founded in 1989, managing approximately $5 billion in assets. The firm specializes in a range of investment strategies, including private equity, venture capital, and public equity, targeting companies across the healthcare spectrum—from startups to large multinational corporations. OrbiMed invests in various sectors within the healthcare industry, including pharmaceuticals, biotechnology, life sciences, medical devices, and health IT. The firm typically invests between $3 million and $150 million, often seeking majority stakes in its portfolio companies. With a global investment approach, OrbiMed operates from offices in New York, San Francisco, Mumbai, Herzliya, Shanghai, West Kowloon, and Luxembourg, focusing on opportunities in North America, Europe, Asia, and Israel. Its investment strategies are underpinned by fundamental analysis, encompassing investments in public equity, fixed income, and alternative markets.

Focus

TherapeuticsScale StageSeries BSeries APharmaceuticalsShow more
http://www.orbimed.com
https://crunchbase.com/organization/orbimed
https://facebook.com/522321737819113
https://linkedin.com/company/orbimed-advisors
https://pitchbook.com/profiles/fund/18001-00F
https://signal.nfx.com/firms/orbimed
https://twitter.com/orbimed
https://www.capitaliq.com/CIQDotNet/company.aspx?companyId=115650
https://www.privateequityinternational.com/database/#/profile?id=6907
601 Lexington Avenue (at 53rd Street), 54th Floor New York, NY 10022-4629
1700 Owens Street Suite 540 San Francisco, CA 94158
Suite F 27, Grand Hyatt Plaza Santacruz (East) Mumbai, 400055, India
89 Medinat HaYehudim St Building E, 11th Floor Herzliya 4614001, Israel
Unit 4706, Raffles City Shanghai Office Tower 268 Xizang Middle Road Shanghai 200001, P.R. China
12/F International Commerce Centre 1 Austin Road West, Unit 01 Kowloon, Hong Kong

Roy Amariglio

Principal

Mona Ashiya

Partner

David Bonita

General Partner

Sven H. Borho

Managing Partner

Vince Burgess

Venture Partner

Evan Caplan

Principal

Erez Chimovits

Partner, Private Equity

Nissim Darvish

Senior Managing Director

Ronny Ginor

Venture Partner

Carl L. Gordon

Managing Partner

Rishi Gupta

Partner

Geoffrey Hsu

General Partner

Samuel D. Isaly

Managing Partner

Mark Jelley

Partner

Chau Khuong

Partner

Kevin Koch

Venture Partner

Anat Naschitz

Managing Director

Carter Neild

Managing Partner

Trevor Polischuk

Partner

Matthew Rizzo

General Partner

William F. Sawyer

Partner

Sunny Sharma

Partner

Michael B. Sheffery

Partner & Co-Founder

Jonathan Silverstein

Partner

Stephen Squinto Ph.D

Partner

C. Scotland Stevens

General Partner

Kerrie Swingle

Director of Investor Services

David G. Wang

Partner

Steven D. Wang

Partner

Jonathan Wang Ph.D

Senior Managing Director

Tal Zaks

Partner

Past deals in Medical

Disc Medicine

Series B in 2021
Disc Medicine, Inc. is a biotechnology company focused on developing therapeutics based on human genetics to address ineffective red blood cell production in hematologic diseases. The company specializes in programs targeting the hepcidin metabolism axis for the treatment of disorders related to hepcidin. Founded in 2017 and headquartered in Cambridge, Massachusetts, Disc Medicine is led by a team of experienced scientists and industry experts, supported by a panel of advisors with a proven history in discovering and developing innovative therapies. The company was established with backing from Atlas Venture, along with contributions from Novo Ventures and Access Biotechnology.

TytoCare

Venture Round in 2020
TytoCare Ltd. develops handheld devices and application that connects people with doctor for an on-demand medical exam, diagnosis, and prescription if needed, anytime, and anywhere. The company’s tools help in examining the heart, lungs, skin, ears, throat, abdomen, and body temperature, and diagnose and treat various common conditions, such as ear infections, cold and flu, fever, headaches, eye irritation, congestion, sinus pain, allergies, sore throat, coughs and upper respiratory issues, bug bites and rashes, constipation, and stomachaches. TytoCare Ltd. has a strategic partnership with Novant Health. The company was incorporated in 2011 and is based in Netanya, Israel with an additional office in New York, New York.

Avedro

Series F in 2018
Medical device and pharmaceutical company advancing the science and technology of corneal cross-linking

TytoCare

Series C in 2018
TytoCare Ltd. develops handheld devices and application that connects people with doctor for an on-demand medical exam, diagnosis, and prescription if needed, anytime, and anywhere. The company’s tools help in examining the heart, lungs, skin, ears, throat, abdomen, and body temperature, and diagnose and treat various common conditions, such as ear infections, cold and flu, fever, headaches, eye irritation, congestion, sinus pain, allergies, sore throat, coughs and upper respiratory issues, bug bites and rashes, constipation, and stomachaches. TytoCare Ltd. has a strategic partnership with Novant Health. The company was incorporated in 2011 and is based in Netanya, Israel with an additional office in New York, New York.

Avedro

Venture Round in 2017
Medical device and pharmaceutical company advancing the science and technology of corneal cross-linking

Avedro

Series E in 2015
Medical device and pharmaceutical company advancing the science and technology of corneal cross-linking

TytoCare

Series B in 2015
TytoCare Ltd. develops handheld devices and application that connects people with doctor for an on-demand medical exam, diagnosis, and prescription if needed, anytime, and anywhere. The company’s tools help in examining the heart, lungs, skin, ears, throat, abdomen, and body temperature, and diagnose and treat various common conditions, such as ear infections, cold and flu, fever, headaches, eye irritation, congestion, sinus pain, allergies, sore throat, coughs and upper respiratory issues, bug bites and rashes, constipation, and stomachaches. TytoCare Ltd. has a strategic partnership with Novant Health. The company was incorporated in 2011 and is based in Netanya, Israel with an additional office in New York, New York.

TytoCare

Series A in 2014
TytoCare Ltd. develops handheld devices and application that connects people with doctor for an on-demand medical exam, diagnosis, and prescription if needed, anytime, and anywhere. The company’s tools help in examining the heart, lungs, skin, ears, throat, abdomen, and body temperature, and diagnose and treat various common conditions, such as ear infections, cold and flu, fever, headaches, eye irritation, congestion, sinus pain, allergies, sore throat, coughs and upper respiratory issues, bug bites and rashes, constipation, and stomachaches. TytoCare Ltd. has a strategic partnership with Novant Health. The company was incorporated in 2011 and is based in Netanya, Israel with an additional office in New York, New York.

OmniGuide

Venture Round in 2012
OmniGuide is a medical device company focused on developing and commercializing minimally invasive surgical tools that utilize CO2 laser technology. Their flagship product, the OmniGuide Beampath CO2 laser energy system, offers a compact solution for precise cutting, ablation, and coagulation, while minimizing thermal damage to surrounding healthy tissue. This versatile system is designed to enhance surgical outcomes by providing high-quality optical scalpels that improve clinical value and expand the possibilities of minimally invasive procedures. The company is dedicated to advancing patient care by delivering indication-specific surgical instruments and exceptional customer service, ultimately aiming to improve patients' quality of life. OmniGuide's products are cleared for sale in the United States and carry CE marking, reflecting their compliance with safety and efficacy standards.

Kerala Institute of Medical Sciences

Venture Round in 2012
Kerala Institute of Medical Sciences is a multi-specialty tertiary care hospital where a team of specialists and sophisticated technology come together to provide high-quality medical aid. The company is committed to reach out to the community and beyond, to make quality healthcare affordable and accessible. It defines every aspect of clinical care, research, and education. Kerala Institute of Medical Sciences invests in the area of quality and safe patient care. The Group also has educational institutions that offer specialized courses for nurses and post-graduate programmes for doctors. It offers 20 DNB (Diplomate of National Board) programmes and Fellowship and International Courses in various specialties and super specialties. It also has College of Nursing, Institute of Skill Development and Paramedical Institute. Kerala Institute of Medical Sciences was founded on 2002 and is headquartered in Thiruvananthapuram, India.